Physician

Brennen Scott Cheek, M.D.

According to 2025 Medicare claims, Brennen Cheek, M.D. (NPI: 1124066139) practices radiation oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Dallas, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1003083445; TIN: 752131429) and primary practice location at 75246-2092.

Cheek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 348 traditional Medicare patients, billed 31,835 HCPCS/CPT codes, and received $6,195,443 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 111 prescription claims across 48 beneficiaries totaling $5,149 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 4 records totaling $65. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,536,224 to $6,195,443. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,261 and ending at $5,149. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	313	12,319	$1,536,224
2016	364	14,991	$1,738,060
2017	362	13,393	$1,586,901
2018	356	11,383	$1,936,445
2019	359	20,230	$2,978,529
2020	411	14,850	$2,395,219
2021	442	21,179	$4,210,608
2022	452	15,555	$2,915,282
2023	340	33,047	$5,966,711
2024	348	31,835	$6,195,443

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	79	$3,261
2016	55	97	$3,579
2017	44	83	$2,646
2018	56	103	$3,717
2019	37	81	$2,643
2020	51	84	$2,279
2021	45	82	$2,661
2022	40	67	$2,363
2023	55	100	$3,438
2024	48	111	$5,149

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	108	974	$279
77263	Complex radiation therapy planning	120	123	$129
77334	Design and construction of complex radiation treatment device	120	287	$96
77014	Ct guidance for insertion of radiation therapy fields	103	871	$94
77300	Calculation of radiation therapy dose	118	746	$51

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	641	$3,890

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$65	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brennen Scott Cheek, M.D.?

Tedicare shows public-source Medicare data for Brennen Scott Cheek, M.D. (NPI 1124066139), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brennen Scott Cheek, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brennen Scott Cheek, M.D.?

Brennen Scott Cheek, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1003083445) in the available physician profile data.

Does Brennen Scott Cheek, M.D. have Open Payments data?

Brennen Scott Cheek, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.